based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Marksans Pharma Ltd. An average target of ₹330.33
Source: S&P Global Market Intelligence
Marksans Pharma Ltd price forecast by 3 analysts
Upside of2.35%
High
₹376
Target
₹330.33
Low
₹265
Marksans Pharma Ltd target price ₹330.33, a slight upside of 2.35% compared to current price of ₹310.5. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Marksans Pharma Ltd revenue growth forecast
Expected growth rate Q1, FY2026:41.23%
Forecast
Actual
Including amortisation and stock based compensations
Marksans Pharma Ltd EPS growth forecast
EPS estimate Q1, FY2026:56.50%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 7.4 % |
3 Month Return | + 20.41 % |
1 Year Return | + 103.31 % |
Market Stats | |
Previous Close | ₹322.75 |
Open | ₹324.50 |
Volume | 13.36L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹14,625.86Cr |
P/E Ratio | 42.13 |
PEG Ratio | 54.72 |
Market Cap | ₹14,625.86 Cr |
P/B Ratio | 5.62 |
EPS | 6.95 |
Dividend Yield | 0.4 |
Sector | Pharmaceuticals |
ROE | 11.46 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹14,625.86 Cr | 446.06% | 0.51 | ₹314 Cr | ₹2,177 Cr | |
NA | ₹302.38 Cr | 124.07% | 0.66 | ₹5 Cr | ₹155 Cr | |
NA | ₹30.65 Cr | 152.18% | 0.50 | NA | NA | |
NA | ₹302.57 Cr | 463.22% | 0.53 | NA | NA | |
NA | ₹255.74 Cr | 146.51% | 0.52 | ₹16 Cr | ₹108 Cr |
Organisation | Marksans Pharma Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Marksans Pharma Ltd
Marksans Pharma Hits New High on Strong Q2 Results - 26 Nov, 2024
Marksans Pharma Secures USFDA Approval for Allergy Drug - 22 Nov, 2024
Marksans Pharma Reports Strong Q3 Growth - 13 Nov, 2024
Marksans Pharma Reports Strong Q2 FY25 Financials - 12 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 7.71% to 10.43% in Sep 2024 quarter
Best in 3 Years
In the last 3 years, MARKSANS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 2.82% to 3.02% in Sep 2024 quarter
Best in 1 Year
In the last 1 year, MARKSANS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
Netprofit is up for the last 3 quarters, 78.29 Cr → 96.72 Cr (in ₹), with an average increase of 10.0% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 576.54 Cr → 652.98 Cr (in ₹), with an average increase of 6.0% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 43.87% of holdings in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 33.78% to 30.71% in Sep 2024 quarter
Price Dip
In the last 7 days, MARKSANS stock has moved down by -7.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 43.87% | 0.00 | |
Foreign Institutions | 10.43% | 35.16 | |
Mutual Funds | 3.02% | 7.44 | |
Retail Investors | 30.71% | ||
Others | 11.96% | 1.24 |
Marksans Pharma Ltd in the last 5 years
Lowest (4.67x)
April 1, 2020
Today (42.13x)
December 11, 2024
Industry (56.82x)
December 11, 2024
Highest (46.60x)
January 24, 2018
Marksans Pharma Ltd’s net profit jumped 15.8% since last year same period to ₹96.72Cr in the Q2 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated 8.98% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Marksans Pharma Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.34%.
Read More about DividendsBearish
Neutral
Bullish
Marksans Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Marksans Pharma Ltd (MARKSANS) share price today is ₹310.5
Marksans Pharma Ltd is listed on NSE
Marksans Pharma Ltd is listed on BSE
PE Ratio of Marksans Pharma Ltd is 42.13
PE ratio = Marksans Pharma Ltd Market price per share / Marksans Pharma Ltd Earnings per share
Today’s traded volume of Marksans Pharma Ltd(MARKSANS) is 13.36L.
Today’s market capitalisation of Marksans Pharma Ltd(MARKSANS) is ₹14625.86Cr.
Marksans Pharma Ltd(MARKSANS | Price |
---|---|
52 Week High | ₹358.7 |
52 Week Low | ₹130 |
Marksans Pharma Ltd(MARKSANS) share price is ₹310.5. It is down -13.44% from its 52 Week High price of ₹358.7
Marksans Pharma Ltd(MARKSANS) share price is ₹310.5. It is up 138.85% from its 52 Week Low price of ₹130
Marksans Pharma Ltd(MARKSANS | Returns |
---|---|
1 Day Returns | -12.25% |
1 Month Returns | 7.4% |
3 Month Returns | 20.41% |
1 Year Returns | 103.31% |